Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +1.73% rallied 2.07% to $347.92 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -1.92% rising 1.39% to 15,448.12 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.17% rising 0.68% to 35,730.48. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $149.57 below its 52-week high ($497.49), which the company reached on August 10th.
The stock outperformed some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.69% rose 1.17% to $109.67, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.63% rose 0.29% to $207.17, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -1.02% rose 0.68% to $62.19. Trading volume (4.6 M) remained 8.1 million below its 50-day average volume of 12.7 M.